vimarsana.com

Latest Breaking News On - Protein sciences segment - Page 4 : vimarsana.com

BIO-TECHNE TO PRESENT AT THE UBS MEDTECH, TOOLS AND GENOMICS SUMMIT 2023

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at.

David clairJim hippelPrnewswire bio techne corporationProtein sciences segmentBio techne corporationInvestor relations corporate developmentTechne corporationExecutive vice presidentChief financial officerGenomics summitInvestor relationsProtein sciencesVice president

BIO-TECHNE RELEASES FOURTH QUARTER FISCAL 2023 RESULTS

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today reported its financial results for the fourth quarter ended June 30, 2023. Fourth Quarter FY2023.

United statesDavid clairChuck kummethWilson wolfPrnewswire bio techne corporationProtein sciencesBio techne corporationProtein sciences segmentCompany protein sciencesCompany diagnosticsChangzhou eminence biotechnology co ltdExchange commissionTechne corporationFinancial measuresChief executive officerGene therapy

BIO-TECHNE TO HOST CONFERENCE CALL ON AUGUST 8, 2023, TO ANNOUNCE FOURTH QUARTER AND FISCAL 2023 FINANCIAL RESULTS

/PRNewswire/ Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Tuesday, August 8, 2023, at.

David clairProtein sciences segmentInvestor relations corporate developmentBio techne corporationPrnewswire bio techne corporationTechne corporationProtein sciencesVice presidentInvestor relations

BIO-TECHNE TO PRESENT AT THE 2023 JEFFERIES HEALTHCARE CONFERENCE

MINNEAPOLIS, May 25, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 Jefferies Healthcare. | May 25, 2023

Jim hippelDavid clairPrnewswire bio techne corporationProtein sciences segmentInvestor relations corporate developmentBio techne corporationTechne corporationExecutive vice presidentChief financial officerHealthcare conferenceInvestor relationsProtein sciencesVice presidentBio techne corporation stock exchangePress releaseEfferies tech us09073m1045

BIO-TECHNE TO PRESENT AT THE 2023 RBC CAPITAL MARKETS GLOBAL HEALTHCARE CONFERENCE

MINNEAPOLIS, May 12, 2023 /PRNewswire/ Bio-Techne Corporation today announced that Jim Hippel, Executive Vice President and Chief Financial Officer, will present at the 2023 RBC Capital Markets. | May 12, 2023

David clairJim hippelInvestor relations corporate developmentBio techne corporationPrnewswire bio techne corporationProtein sciences segmentTechne corporationExecutive vice presidentChief financial officerMarkets global healthcare conferenceInvestor relationsProtein sciencesVice presidentBio techne corporation stock exchangePress releaseApital tech us09073m1045

vimarsana © 2020. All Rights Reserved.